Meningococcal serogroup B vaccines

被引：0
|
作者：
Dommergues, M. -A. [1 ]
机构：
[1] Ctr Hosp Versailles, F-78150 Le Chesnay, France
来源：
ARCHIVES DE PEDIATRIE | 2012年 / 19卷
关键词：
RECOMBINANT PROTEIN; TAILOR-MADE; COVERAGE; SAFETY;
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
The diversity and antigenic variability of Neisseria meningitidis serogroup B strains around the world has been a major challenge to developing a vaccine with broad coverage. Outer-membrane vesicle vaccines appear to be safe and effective but are strain-specific vaccines and used in delimited areas. Also, recombinant protein vaccines such as factor H binding protein, given alone or in combination with others antigens have been developed and may be effective against the majority of group B strains. (c) 2012 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：S65 / S69
页数：5
相关论文
共 50 条
  • [21] Use of Serogroup B Meningococcal Vaccines in Persons Aged ≥ 10 Years at Increased Risk for Serogroup B Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2015
    Folaranmi, Temitope
    Rubin, Lorry
    Martin, Stacey W.
    Patel, Manisha
    MacNeil, Jessica R.
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2015, 64 (22): : 608 - 612
  • [22] Evaluation of serogroup A meningococcal vaccines in Africa:: A demonstration project
    Soriano-Gabarró, M
    Rosenstein, N
    LaForce, FM
    JOURNAL OF HEALTH POPULATION AND NUTRITION, 2004, 22 (03) : 275 - 285
  • [23] Implementation Experience With Meningococcal Serogroup B Vaccines in the United States Impact of a Nonroutine Recommendation
    Fergie, Jaime
    Howard, Ashley
    Huang, Liping
    Srivastava, Amit
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2021, 40 (03) : 269 - 275
  • [24] A SYSTEMATIC REVIEW: COST-EFFECTIVENESS OF VACCINATION WITH NEW MENINGOCOCCAL SEROGROUP B VACCINES
    Smit, R.
    VALUE IN HEALTH, 2018, 21 : S238 - S238
  • [25] Immunogenicity and safety of a combination of two serogroup B meningococcal outer membrane vesicle vaccines
    Sandbu, Synne
    Feiring, Berit
    Oster, Philipp
    Helland, Oddveig S.
    Bakke, Hilde S. W.
    Naess, Lisbeth M.
    Aase, Audun
    Aaberge, Ingeborg S.
    Kristoffersen, Anne-Cathrine
    Rydland, Kjersti M.
    Tilman, Sandrine
    Nokleby, Hanne
    Rosenqvist, Einar
    CLINICAL AND VACCINE IMMUNOLOGY, 2007, 14 (09) : 1062 - 1069
  • [26] Use of available outer membrane vesicle vaccines to control serogroup B meningococcal outbreaks
    Taha, Muhamed-Kheir
    Zarantonelli, Maria Leticia
    Alonso, Jean-Michel
    Naess, Lisbeth Meyer
    Holst, Johan
    Feiring, Berit
    Rosenqvist, Einar
    VACCINE, 2007, 25 (14) : 2537 - 2538
  • [27] Prevention of serogroup B meningococcal disease
    Stephens, David S.
    LANCET, 2012, 379 (9816): : 592 - 594
  • [28] The burden of serogroup B meningococcal disease
    van de Beek, Diederik
    LANCET NEUROLOGY, 2012, 11 (09): : 743 - 745
  • [29] Trumenba: A Serogroup B Meningococcal Vaccine
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2015, 57 (1459): : 5 - 6
  • [30] An effective serogroup B meningococcal vaccine
    Dominguez, Francisco
    Menendez, Jorge
    Ochoa, Rolando
    VACCINE, 2006, 24 (49-50) : 7025 - 7026
12345